#Electromyography Devices Market

[bhushans]

Bridging the Gap: How the Global Electromyography Devices Market is Expanding Access to Care

The global electromyography devices market will grow quickly, and by 2033, it is expected to be worth USD 1,753 million. This notable increase from its predicted value of USD 908 million in 2023 is a result of its strong Compound Annual Growth Rate (CAGR) of 6.8% during the forecast timeframe.

Electromyography (EMG) devices provide clinicians with crucial insights into the anatomy and physiology of muscles and nerves, making them a useful diagnostic and treatment tool for neuromuscular disorders. These gadgets assist medical practitioners in evaluating nerve transmission, spotting abnormalities, and monitoring the progression of illnesses by detecting the electrical activity generated by muscle contractions.

Deepen Understanding With Your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3971

Technological developments in the field of electromyography are leading to improvements in accessibility, patient comfort, and therapeutic accuracy. Examples of these developments include the creation of wireless, portable, and easily navigable systems. These advancements make it possible for medical professionals to do EMG checks in a variety of locations, which helps with the early detection and treatment of neuromuscular problems.

Rising Demand for Neuromuscular Disorder Diagnosis

The primary cause of this development is the rising incidence of neuromuscular conditions such ALS, myopathy, motor neuron illnesses, myasthenia gravis, and Parkinson’s disease. The market for EMG devices is predicted to grow as less invasive operations become more common in the diagnosis and treatment of various disorders.

There is no denying these illnesses have a substantial worldwide impact. The Global Institute for Health Metrics and Evaluation estimates that approximately 237,000 people died from motor neuron disease alone in 2017. In a similar vein, the Parkinson’s disorder Foundation states that the disorder affects over 10 million people globally. The market for EMG devices is being driven ahead in large part by the increasing prevalence of neuromuscular illnesses.

Technological Advancements and Portability Drive Innovation

The industry is additionally stimulated by the continuous progress in EMG technology. For example, the introduction of portable EMG devices permits greater simplicity of usage and flexibility. The RS-EMGX EMG system is one example of such innovation; it enables the simultaneous recording of four channels of EMG from a single participant. It is expected that these technological advancements would have a major impact on market growth in the upcoming years.

Key Takeaways from the Electromyography (EMG) Devices Market:

The United States market leads the North American electromyography devices market in terms of market share in North America. The United States held a leading market share of 35.7% in 2022. The factors attributed to the growth are world-class healthcare systems, higher technological penetration in healthcare systems, higher bandwidth internet, and integration of smart technologies. The North American region held a market share of 38.4% of the global market in 2022.

The German electromyography devices market held a healthy market share of 11.1% in 2022. The market growth is caused by the government’s focus on public health and innovation. The increasing geriatric population is also putting healthcare authorities on their toes to upgrade their systems with the recent versions. The European region accounted for a fair share of 29.2% of the global EMG devices market in 2022.

The Indian market thrives at a healthy CAGR of 7.8% between 2023 and 2033. The growth is attributed to the country building new multi-specialty hospitals and renovating their healthcare systems.

China’s electromyography market thrives at a CAGR of 8.3% between 2023 and 2033.

Based on modality, the standalone devices lead the segment as it held a market share of 71.1% in 2022.

Based on end-user type, the hospital segment aces the category as it held a market share of 42.1% in 2022.

Market Competition:

Compumedics Limited, Cadwell Laboratories Inc., Covidien Limited, Electrical Geodesics Inc., Natus Medical Inc., Nihon Kohden America Inc., NeuroWave Systems Inc., and Noraxon U.S.A.; Inc. are key participants in the worldwide electromyography devices market.

Recent Developments

In February 2021, Cadwell acquired Sleepmate Sleep Diagnostic Sensors from Ambu A/S. Cadwell is a pioneer in neurodiagnostic and neuromonitoring solutions.

In July 2020, Magtism, the global leader in Transcranial Magnetic Stimulation (TMS), announced an agreement to acquire the product portfolio of Electrical Geodesics Inc. from Royal Philips. Magtism acquired EGI hardware, sensor net assets, and software and handle global sales.

Nihon Kohden America Inc. has introduced its EMG/NCV/EP measuring desktop system with a six or twelve-channel amplifier and up to two electrical stimulators.

Key Players:

Compumedics Limited

Cadwell Laboratories Inc.

Covidien Limited

Electrical Geodesics Inc.

Natus Medical Inc.

Nihon Kohden America Inc.

NeuroWave Systems Inc.

Noraxon U.S.A. Inc.

Key Segments Covered:

By Modality:

Portable

Standalone

By End User:

Clinics

Hospitals

Rehabilitation Centers

Homecare Centers

By Region:

North America

United States

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Europe

Germany

United Kingdom

France

Spain

Russia

Rest of Europe

Japan

Asia Pacific Excluding Japan

China

India

Malaysia

Singapore

Australia

Rest of Asia Pacific Excluding Japan (APEJ)

The Middle East and Africa

GCC Countries

Israel

South Africa

Middle East and Africa (MEA)

[insightslicelive]

Electromyography Devices Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | NIHON KOHDEN, Cadwell Industries, Compumedics

Electromyography Devices Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | NIHON KOHDEN, Cadwell Industries, Compumedics

An overview of the market segment, size, share, sectional analysis, and revenue forecast, as well as a complete analysis, are included in the Electromyography Devices Market study. It engulfs micro and macroeconomic factors, industry trends, dynamics, and the strengths and weaknesses of the top competitors. It also includes details on sales channels, distributors, traders, and dealers, as well as…

[marketsreport]

Electroencephalogram (EEG) equipment is widely utilized to monitor the electrical activity of the brain. It relies on electrodes, amplifiers, filters and an analog to digital converter to record brain wave patterns and send the data to a computer or cloud device. It finds application in diagnosing conditions, such as seizures, epilepsy, head injuries, dizziness, headaches, brain tumors and sleeping disorders. On the other hand, electromyography (EMG) equipment helps evaluate the electrical activity in skeletal muscles. 

[tritonmarketresearchamey]

Epilepsy Devices Market: Tech Trends 2022-2028

According to the WHO, epilepsy is a chronic brain disorder that affects 50 million individuals, making it one of the most prevalent neurological conditions worldwide. It is estimated that with access to early detection and appropriate care, 70% of the population diagnosed with epilepsy may live seizure-free. According to our estimates, the global epilepsy devices market was valued at $669.73 million in 2021 and is expected to reach $1157.58 million by 2028, growing at a CAGR of 8.16% during the forecast period 2022-2028.

Government institutions worldwide are focused on starting initiatives to create innovative epilepsy devices with AI and machine learning integration. Additionally, organizations that support research need to encourage high-quality comparative efficacy trials and sufficient data to guide therapeutic practice in epilepsy. As a result of these technologically advanced equipment and increasing drug trials, the market for epilepsy devices is anticipated to grow throughout the forecast period.

Epilepsy Devices - Key Detection Methodologies

Currently, several wearable technologies can detect seizures, collect data, and alert caregivers. Although with technological advancements, the ability to detect seizure-related alterations increases. Top trends backing this tech boom include:

Wearable devices are estimated to be the fastest-growing device type during the forecast period. Monitoring epileptic patients is crucial, as 20% of epileptics only have seizures while asleep, 40% only have seizures while awake, and 35% have seizures both when they are awake and asleep. With technologically advanced non-invasive wearable sensors, measuring accelerometry, photoplethysmography (PPG), electrodermal activity (EDA), electromyography (EMG), and other signals outside of the conventional clinical environment have become effective.

Vagus Nerve Stimulation (VNS) has emerged as the fastest-growing application category. VNS Therapy has been approved by the U.S. Food and Drug Administration (FDA) as an add-on therapy for age 4 years and above to treat drug-resistant epilepsy or refractory epilepsy. VNS has been reportedly beneficial in many patients, including the ones with posttraumatic epilepsy (PTE). PTE is a common consequence of traumatic brain injury and accounts for about 20% of symptomatic epilepsy cases.

As per estimates, Electroencephalography lead the detection and prediction devices type segment in 2021 and is expected to maintain its stronghold during the forecast period. There is growing interest in wearable or mobile EEG solutions that allow long‐term EEG monitoring in an easy‐to‐use format. Despite the availability of these new EEG solutions, their adoption is still limited in clinical practice, mainly because of the unfamiliarity of healthcare and biomedical research sectors with the technology and its application.

Strategic Initiatives and Government Approvals

Different end-users, such as homecare settings, hospitals, and clinics, are utilizing epilepsy devices. The manufacturers of epilepsy monitoring devices are likely to gain prominent business opportunities from the hospital & clinics segment owing to the rise in the use of EEG monitoring and emergency medical services.

The government authorities of several developing nations, including India and China, are focusing on developing sturdy healthcare infrastructure. As a result, operating players are expected to gain sizable growth prospects in the region during the forecast period. Owing to this, the Asia Pacific epilepsy devices market is anticipated to witness the fastest growth with a CAGR of 8.38% throughout the forecast period.

In addition, companies are also focusing on launching novel devices for children. Moreover, companies are also using organic and inorganic strategies, including mergers and acquisitions, to stay ahead of the competition. Some of these include:

In September 2022, Boston Scientific Corporation’s current-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling. The company also received FDA 510(k) clearance for the EMBOLD Fibered Detachable Coil, which reduces the blood flow rate in the peripheral vasculature.

In July 2022, Medtronic PLC received FDA 510(k) clearance for its UNiD Spine Analyzer v4.0 planning platform to leverage machine learning.

In November 2021, NeuroPace, Inc. received an Investigational Device Exemption (IDE) from the FDA to study the company’s RNS System to treat primary generalized epilepsy in patients aged 12 and above.

Way Forward

With technological advancements, epilepsy detection devices with exceptionally low false alarm rates have recently been developed. They are based on computationally intensive algorithms and employed in implanted systems for pre-surgical monitoring. Recent research has produced encouraging findings for probabilistic seizure risk projections using long-term wearable technology and electronic seizure diaries. The symptoms, mood, and cognitive function of an individual may also have predictive significance. Therefore, technological advances in non-invasive wearable sensors are anticipated to create growth opportunities for the epilepsy devices market.

 

FAQ:

Q1) What are the key end-users of the epilepsy devices market?

The key end-users in the epilepsy devices market include hospitals & clinics, neurology centers, homecare settings, and other end-users.

Q2) Which region leads the global epilepsy devices market?

North America leads the global epilepsy devices market.

[marketpattern]

 Elbow Lesion Treatment Market Strategies for Growth, Segmentation, and Market Overview by 2024-2031

The "Elbow Lesion Treatment Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political, economic, social, technological, environmental, and legal factors. Expert opinions and recent developments highlight the geographical distribution and forecast the market's trajectory, ensuring a robust foundation for strategic planning and investment.

What is the projected market size & growth rate of the Elbow Lesion Treatment Market?

Market Analysis and Size

Increased occurrences of sport-related bone diseases and increased advancement in the innovative treatment for joint & bone-related conditions will boost the global elbow lesion treatment market. Elbow disorders can be diagnosed by physical examination, x-rays, magnetic resonance imaging, electromyography, computerized tomography scan, and biopsy of bursa fluid. Several new advancements in minimally invasive surgeries by medical device manufacturers are majorly focusing on evolving economies due to large patient base and growing demand for bone-related surgeries.

Data Bridge Market Research analyses a growth rate in the global elbow lesion treatment market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Browse Detailed TOC, Tables and Figures with Charts which is spread across 350 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.

This research report is the result of an extensive primary and secondary research effort into the Elbow Lesion Treatment market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Elbow Lesion Treatment Market.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-elbow-lesion-treatment-market

Which are the driving factors of the Elbow Lesion Treatment market?

The driving factors of the Elbow Lesion Treatment market include technological advancements that enhance product efficiency and user experience, increasing consumer demand driven by changing lifestyle preferences, and favorable government regulations and policies that support market growth. Additionally, rising investment in research and development and the expanding application scope of Elbow Lesion Treatment across various industries further propel market expansion.

Elbow Lesion Treatment Market - Competitive and Segmentation Analysis:

Global Elbow Lesion Treatment Market, Treatment Surgical, Non-Surgical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2031.

How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Which are the top companies operating in the Elbow Lesion Treatment market?

Key players operating in the global elbow lesion treatment market include:

Zimmer Biomet (U.S.)

Stryker Corporation (U.S.)

ExaTech Inc. (U.S.)

Arthrex, Inc. (U.S.)

Takeda Pharmaceutical Company Limited (Japan)

Medacta International (Switzerland)

Short Description About Elbow Lesion Treatment Market:

The Global Elbow Lesion Treatment market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

North America, especially The United States, will still play an important role which can not be ignored. Any changes from United States might affect the development trend of Elbow Lesion Treatment. The market in North America is expected to grow considerably during the forecast period. The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the market.

Europe also play important roles in global market, with a magnificent growth in CAGR During the Forecast period 2024-2031.

Elbow Lesion Treatment Market size is projected to reach Multimillion USD by 2031, In comparison to 2024, at unexpected CAGR during 2024-2031.

Despite the presence of intense competition, due to the global recovery trend is clear, investors are still optimistic about this area, and it will still be more new investments entering the field in the future.

This report focuses on the Elbow Lesion Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a Sample Copy of the Elbow Lesion Treatment Report 2024

What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report. Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

What are the key regions in the global Elbow Lesion Treatment market?

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

This Elbow Lesion Treatment Market Research/Analysis Report Contains Answers to your following Questions

What are the global trends in the Elbow Lesion Treatment market?

Would the market witness an increase or decline in the demand in the coming years?

What is the estimated demand for different types of products in Elbow Lesion Treatment?

What are the upcoming industry applications and trends for Elbow Lesion Treatment market?

What Are Projections of Global Elbow Lesion Treatment Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?

Where will the strategic developments take the industry in the mid to long-term?

What are the factors contributing to the final price of Elbow Lesion Treatment?

What are the raw materials used for Elbow Lesion Treatment manufacturing?

How big is the opportunity for the Elbow Lesion Treatment market?

How will the increasing adoption of Elbow Lesion Treatment for mining impact the growth rate of the overall market?

How much is the global Elbow Lesion Treatment market worth? What was the value of the market In 2020?

Who are the major players operating in the Elbow Lesion Treatment market? Which companies are the front runners?

Which are the recent industry trends that can be implemented to generate additional revenue streams?

What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Elbow Lesion Treatment Industry?

Customization of the Report

Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Inquire more and share questions if any before the purchase on this report at - https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-elbow-lesion-treatment-market

Detailed TOC of Global Elbow Lesion Treatment Market Insights and Forecast to 2031

Introduction

Market Segmentation

Executive Summary

Premium Insights

Market Overview

Elbow Lesion Treatment Market By Type

Elbow Lesion Treatment Market By Function

Elbow Lesion Treatment Market By Material

Elbow Lesion Treatment Market By End User

Elbow Lesion Treatment Market By Region

Elbow Lesion Treatment Market: Company Landscape

SWOT Analysis

Company Profiles

Continued...

Purchase this report – https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-elbow-lesion-treatment-market

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975

Email:- corporatesales@databridgemarketresearch.com

Browse More Reports:

Global Arthroscopic Shavers Market – Industry Trends and Forecast to 2028

Global Opaque Polymers Market – Industry Trends and Forecast to 2029

Global Commercial Aviation Crew Management Systems Market – Industry Trends and Forecast to 2029

Global Elbow Lesion Treatment Market – Industry Trends and Forecast to 2029

Global Automotive Intelligence Park Assist System Market – Industry Trends and Forecast to 2028

[mrfr-blogs]

Size Matters: Evaluating the Intraoperative Neurophysiological Monitoring Market Share

Market Overview –

The size of the intraoperative neurophysiological monitoring market was estimated at USD 1.8 billion in 2022 and is expected to increase at a compound annual growth rate (CAGR) of 8.9% between 2023 and 2032, from USD 1.96 billion in 2023 to USD 3.86 billion.

The intraoperative neurophysiological monitoring (IONM) market focuses on the use of monitoring techniques to assess the integrity and function of the nervous system during surgical procedures. IONM involves recording and analyzing electrical signals from the brain, spinal cord, and peripheral nerves in real-time to prevent neurological complications and optimize surgical outcomes.

Market growth is driven by the increasing demand for IONM in complex surgeries, such as spinal, cranial, and peripheral nerve surgeries, where the risk of neurological damage is high. IONM provides valuable insights into nerve function, enabling surgeons to make informed decisions, minimize the risk of neurological injury, and improve patient safety and outcomes.

 The Intraoperative Neurophysiological Monitoring Market is experiencing rapid growth due to the increasing demand for neurophysiologic monitoring during surgical procedures. These monitoring techniques help surgeons assess nerve function in real-time, reducing the risk of neurological damage. With advancements in technology and rising awareness about patient safety, the market is poised for continued expansion.

Technological advancements and innovations in IONM systems and techniques are shaping the market, offering new monitoring modalities, software algorithms, and hardware platforms to enhance monitoring accuracy, sensitivity, and reliability. From multi-channel electrode arrays and nerve stimulation devices to advanced signal processing algorithms and remote monitoring capabilities, these advancements improve surgical workflow efficiency and patient care.

Moreover, the COVID-19 pandemic has underscored the importance of IONM in maintaining patient safety and optimizing surgical resources, as healthcare systems face challenges such as resource constraints and patient prioritization. IONM enables surgeons to perform complex procedures more safely and efficiently, reducing the need for reoperations and postoperative complications, driving market growth and innovation in the surgical field.

However, challenges such as reimbursement issues, variability in practice guidelines, and the need for specialized training pose obstacles to market growth. Addressing these challenges requires collaboration between healthcare providers, industry stakeholders, and regulatory agencies to develop standardized protocols, ensure quality assurance, and promote the adoption of IONM best practices.

Overall, the intraoperative neurophysiological monitoring market presents significant opportunities for innovation and collaboration to improve surgical outcomes and patient care. By investing in research, education, and technology, stakeholders can drive continued growth and advancement in the market and contribute to the advancement of neurosurgery and neuromonitoring practices.

Segmentation –

The segmentation of the intraoperative neurophysiological monitoring market is carried out on the basis of type, procedure, methods, source, and region. Based on type, the intraoperative neurophysiological monitoring market is segmented into electromyography, electroencephalography, and evoked potentials. On the basis of procedure, the intraoperative neurophysiological monitoring market is segmented into otolaryngology surgery, spinal, neurovascular, orthopedic, and urology. The segmentation of the market based on the methods consists of non-invasive, invasive, and minimally invasive. Based on source, the intraoperative neurophysiological monitoring market comprises of outsourced, in-house, and telehealth. By region, the intraoperative neurophysiological monitoring market consists of Europe, Asia Pacific, North America, Middle East, and Africa.

Regional Analysis –

Regional analysis of the Intraoperative Neurophysiological Monitoring (IONM) Market provides valuable insights into the distribution and trends of neurophysiological monitoring procedures during surgeries across different geographic areas. Understanding regional dynamics is crucial for stakeholders to tailor their strategies effectively, considering factors such as the prevalence of neurological conditions, availability of healthcare facilities, and adoption of advanced surgical techniques.

For instance, regions with a higher incidence of complex surgeries involving the nervous system, such as spinal or brain surgeries, may witness increased demand for IONM services to ensure optimal patient safety and surgical outcomes. Developed regions with sophisticated healthcare infrastructure often have well-established IONM programs integrated into surgical protocols, enabling real-time monitoring of neural functions during procedures. Conversely, developing regions may face challenges such as limited access to trained neurophysiologists, lack of standardized protocols, and inadequate resources for IONM equipment.

Factors like government healthcare spending, reimbursement policies, and advancements in medical technology also influence regional dynamics in the IONM market. By conducting a comprehensive regional analysis, stakeholders can identify growth opportunities, assess competitive landscapes, and tailor their strategies to meet the specific needs of each region. Moreover, understanding regional variations in surgical practices and patient demographics enables the development of targeted interventions and educational programs to promote the adoption of IONM and improve surgical outcomes worldwide. Overall, regional analysis serves as a vital tool for optimizing resource allocation, enhancing patient safety, and driving innovation in the IONM market.

Key Players –

Intraoperative neurophysiological monitoring key companies include Cadwell Laboratories, IntraNerve, NeuroMonitoring Technologies, ProPep Surgical, Sentient Medical Systems, Accurate Monitoring LLC, Natus Medical Incorporated, NuVasive, Medsurant Holdings, and Inomed Medizintechnik GmbH.

Related Reports –

Medical Tourniquets

Forensic Swab

Ascites

Intraoperative Neurophysiological Monitoring

For more information visit at MarketResearchFuture

[kirancmi]

Bioelectronics Market Is Estimated To Witness High Growth Owing To Rising Applications In Healthcare

Bioelectronics is an interdisciplinary field that involves the merging of biology and electronics to develop devices and systems that combine biological and synthetic materials. Bioelectronics has applications in healthcare for developing implantable and wearable medical devices for monitoring health parameters such as electrocardiograms (ECG), electromyography (EMG), and electroencephalograms (EEG). Biosensors integrated into these devices can analyze blood, sweat or tissue samples to detect biomarkers for diseases. The global bioelectronics market is estimated to be valued at US$ 23530 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics The rising applications of bioelectronics in healthcare is driving the growth of the global bioelectronics market. Bioelectronic devices aid in monitoring health parameters remotely and continuously, thereby improving disease diagnosis and management. This is expected to support market growth over the forecast period. Further, ongoing research focused on the development of advanced bioelectronic medicines is also fueling demand. For instance, researchers are working on developing electronic drug delivery systems coupled with biological components to treat diseases including diabetes, cancer, or inflammatory conditions with tailored drug release profiles. However, high costs associated with developing advanced bioelectronic systems and obtaining regulatory approvals pose a challenge to market players. SWOT Analysis Strength: Bioelectronics technology has capabilities that could positively impact and advance healthcare. It has the potential to improve disease diagnosis and monitoring through more precise and personalized detection methods. Devices incorporating bioelectronics may help enhance treatment through remote monitoring and administration of therapies. This represents a strength as patients could benefit significantly from more proactive and tailored care approaches. Weakness: The bioelectronics field is still developing and refinements are ongoing to further strengthen performance of devices and integrate biocompatible materials. This presents some uncertainties that may discourage adoption until technologies achieve more proven results at commercial scales. Obtaining regulatory approval for new classes of medical devices can be lengthy and costly as well. Opportunity: An aging global population is driving demand for advanced healthcare solutions. The medical technology industry is actively investing in bioelectronics as a means to deliver personalized care for chronic diseases and conditions. This growing preventive medicine trend presents commercial opportunities as new types of diagnostic tools and therapeutic devices are brought to markets. Biosensors also show promise for applications in food safety, environmental monitoring and national security. Threats: Competing drug and device manufacturers may attempt to delay market entry of disruptive new bioelectronics through regulatory and legal challenges. Strict rules govern biosensing technologies and any adverse events involving new products could damage brands. Rapid changes occurring as the field evolves also present technical threats if standards and interfaces are not adequately stabilized before broad adoption. Key Takeaways The global bioelectronics market forecast is expected to witness high growth over the forecast period of 2023 to 2030 supported by a growing aging population with chronic conditions seeking more advanced healthcare solutions. The global bioelectronics market is estimated to be valued at US$ 23530 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

Regional analysis: The Asia Pacific region is dominating the global bioelectronics market with the highest growth rate over the forecast period. This can be attributed to factors such as rising medical expenditures, expanding biotechnology industries, and government initiatives and investments promoting development of indigenous bioelectronic technologies particularly in India, China, and South Korea. The large patient pools and growing middle-class populations seeking access to advanced healthcare in Asia Pacific economies also contribute to high market potential.

Key players operating in the bioelectronics market are BBI-Biotech GmbH Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc. Leading players are focused on new product approvals, partnerships and acquisitions to enhance their product portfolio and geographic presence in this rapidly evolving industry.

Get more insights on this topic: https://www.newsstatix.com/bioelectronics-market-industry-insights-trends-bioelectronics-market/

Explore more information on this topic, Please visit: https://www.urdughr.com/2023/12/recycled-construction-aggregates-a-sustainable-solution-for-growing-construction-needs.html

[giyadesuza]

Spinal Muscular Atrophy Disease Diagnosis: The Crucial First Step Towards Treatment

Spinal Muscular Atrophy Disease Overview:

Spinal Muscular Atrophy (SMA) Disease is a rare and debilitating genetic disorder that primarily affects children and young adults. It is characterized by the progressive degeneration of motor neurons in the spinal cord, leading to muscle weakness and, in severe cases, respiratory failure. SMA is a challenging condition that necessitates an in-depth understanding of its diagnostic and treatment approaches, as well as the evolving landscape of the disease market.

The Market Competitors Listed Below are Revolutionizing Healthcare with Innovative Inventions:

Diagnostic Market Players-

Elitech Group

Perkinelmer inc.

Human-Device Interaction Lab

Bio-Rad

PHC Corporation

Randox Laboratories

Price & Market Access

Spinal Muscular Atrophy Diagnostic Analysis:

Early Diagnosis is Crucial:

Early diagnosis is essential for SMA, as the severity of symptoms and the course of the disease can vary widely. Diagnostic tests include genetic screening, blood tests, and electromyography (EMG) to assess muscle function. Genetic testing, in particular, can confirm the presence of SMN1 gene mutations, which are responsible for SMA.

Screening Programs:

Many countries have implemented newborn screening programs for SMA to facilitate early detection. Newborn screening allows for proactive intervention, which can significantly improve the quality of life for affected individuals.

Spinal Muscular Atrophy Treatment Analysis:

Historical Challenges:

SMA used to have limited treatment options, but recent years have seen groundbreaking developments. Historically, management was primarily supportive and focused on symptom alleviation. This often-involved physiotherapy, respiratory support, and adaptive devices to enhance daily living.

Revolutionary Therapies:

The advent of innovative therapies has transformed the landscape of SMA treatment. Medications such as nusinersen (Spinraza) and onasemnogene abeparvovec (Zolgensma) offer a more direct approach by addressing the underlying genetic cause of the disease. These therapies aim to increase the production of the survival motor neuron (SMN) protein and have shown promising results in clinical trials.

Ongoing Research:

Research into SMA is ongoing, with a focus on refining existing treatments and developing new therapeutic options. Gene therapies and small molecules are among the promising avenues of exploration.

Expanding Spinal Muscular Atrophy Disease Market:

The SMA market has witnessed significant growth due to the emergence of novel treatments. The global market has expanded rapidly as more patients gain access to these life-changing therapies. Market expansion can be attributed to increased awareness, early diagnosis, and the introduction of innovative drugs.

Regulatory Framework for Spinal Muscular Atrophy:

FDA's Role:

The U.S. Food and Drug Administration (FDA) has played a pivotal role in the regulation of SMA therapies. Their fast-tracking and approval of groundbreaking drugs like Zolgensma and Spinraza have set a precedent for accelerating the development and approval of treatments for rare diseases.

Browse More Information:

International Collaboration:

Regulatory bodies worldwide are cooperating to streamline the approval process for SMA treatments, making it easier for patients to access these potentially life-saving therapies.

Competitive Analysis:

Several pharmaceutical companies are competing in the SMA market. Biogen (for Spinraza) and Novartis (for Zolgensma) are among the frontrunners, but many other companies are investing in research and development to introduce their SMA therapies.

Market Trends:

Orphan Drug Designation:

SMA therapies often receive orphan drug designation, which grants incentives to pharmaceutical companies for developing drugs for rare diseases. This trend promotes investment in SMA research and development.

Expanding Access:

Efforts are underway to ensure that SMA therapies are accessible to a broader population. This includes advocating for insurance coverage, reducing treatment costs, and increasing the availability of these drugs in different regions.

Clinical Trial Data Assessment:

The clinical trial data for SMA therapies has demonstrated remarkable outcomes, showing significant improvements in motor function and quality of life for patients. These therapies have the potential to be game changers in the field of rare disease treatment.

Conclusion:

Spinal Muscular Atrophy is a challenging disease that primarily affects the younger generation, often with devastating consequences. However, the landscape of SMA is evolving rapidly, with revolutionary therapies and increased awareness improving the lives of those affected. Early diagnosis, innovative treatments, and international collaboration within the regulatory framework are all contributing to a brighter future for SMA patients. As research and development efforts continue, the SMA market will likely see further growth, expanding access and offering hope to individuals and families dealing with this rare genetic disorder.

Browse Through More Genetic Diseases Research Reports

Related Reports:

Fanning the Flames Within: Navigating the Complex World of Pancreatitis Disease

Appendicitis Disease Unveiled: Understanding the Ache of the Appendix

Clotting Conundrum: Unraveling the Mysteries of Hemophilia Disease

Unveiling the Tiny Culprit: Demodex Blepharitis - A Closer Look at an Ocular Infestation

Battling the Breath of Life: A Deep Dive into Cystic Fibrosis.

Contact Us:   

Disease Landscape Insights LLP   

6th Floor, Sr No.207, Office A H 6070 Phase 1   

Solitaire Business Hub, Viman Nagar   

Pune, Maharashtra, 411014. 

Sales Contact: +44-2038074155   

Asia Office Contact: +917447409162   

Email: ajay@diseaselandscape.com     

Email: vishal@diseaselandscape.com 

Blog: https://www.diseaselandscape.com/blogs 

Case Study: https://www.diseaselandscape.com/casestudies     

Pharma consulting Services   

Follow Us: LinkedIn | Twitter | Facebook

[custommarketinsightsreports]

https://www.custommarketinsights.com/report/electromyography-devices-market/

[bhushans]

Bridging the Gap: How the Global Electromyography Devices Marketis Expanding Access to Care

The global electromyography devices market would develop at a robust rate, with a predicted value of US$1,753 million by 2033. Its robust Compound Annual Growth Rate (CAGR) of 6.8% for the projected period is seen in this significant growth from its estimated value of US$908 million in 2023.

Electromyography (EMG) devices are an invaluable diagnostic and therapeutic tool for neuromuscular disorders, giving physicians critical insights into the anatomy and physiology of muscles and nerves. By detecting the electrical activity produced by muscle contractions, these devices help medical professionals assess nerve transmission, identify anomalies, and track the development of diseases.

Deepen Understanding With Your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3971

Technological advancements in the design of electromyography equipment, such as the development of wireless, portable, and user-friendly systems, are also enabling advances in accessibility, patient comfort, and therapeutic accuracy. These developments facilitate early detection and treatment of neuromuscular disorders by enabling medical personnel to perform EMG exams in a range of settings.

Rising Demand for Neuromuscular Disorder Diagnosis

The primary cause of this development is the rising incidence of neuromuscular conditions such ALS, myopathy, motor neuron illnesses, myasthenia gravis, and Parkinson’s disease. The market for EMG devices is predicted to grow as less invasive operations become more common in the diagnosis and treatment of various disorders.

There is no denying these illnesses have a substantial worldwide impact. The Global Institute for Health Metrics and Evaluation estimates that approximately 237,000 people died from motor neuron disease alone in 2017. In a similar vein, the Parkinson’s disorder Foundation states that the disorder affects over 10 million people globally. The market for EMG devices is being driven ahead in large part by the increasing prevalence of neuromuscular illnesses.

Technological Advancements and Portability Drive Innovation

The industry is additionally stimulated by the continuous progress in EMG technology. For example, the introduction of portable EMG devices permits greater simplicity of usage and flexibility. The RS-EMGX EMG system is one example of such innovation; it enables the simultaneous recording of four channels of EMG from a single participant. It is expected that these technological advancements would have a major impact on market growth in the upcoming years.

Key Takeaways from the Electromyography (EMG) Devices Market:

The United States market leads the North American electromyography devices market in terms of market share in North America. The United States held a leading market share of 35.7% in 2022. The factors attributed to the growth are world-class healthcare systems, higher technological penetration in healthcare systems, higher bandwidth internet, and integration of smart technologies. The North American region held a market share of 38.4% of the global market in 2022.

The German electromyography devices market held a healthy market share of 11.1% in 2022. The market growth is caused by the government’s focus on public health and innovation. The increasing geriatric population is also putting healthcare authorities on their toes to upgrade their systems with the recent versions. The European region accounted for a fair share of 29.2% of the global EMG devices market in 2022.

The Indian market thrives at a healthy CAGR of 7.8% between 2023 and 2033. The growth is attributed to the country building new multi-specialty hospitals and renovating their healthcare systems.

China’s electromyography market thrives at a CAGR of 8.3% between 2023 and 2033.

Based on modality, the standalone devices lead the segment as it held a market share of 71.1% in 2022.

Based on end-user type, the hospital segment aces the category as it held a market share of 42.1% in 2022.

Market Competition:

Compumedics Limited, Cadwell Laboratories Inc., Covidien Limited, Electrical Geodesics Inc., Natus Medical Inc., Nihon Kohden America Inc., NeuroWave Systems Inc., and Noraxon U.S.A.; Inc. are key participants in the worldwide electromyography devices market.

Recent Developments

In February 2021, Cadwell acquired Sleepmate Sleep Diagnostic Sensors from Ambu A/S. Cadwell is a pioneer in neurodiagnostic and neuromonitoring solutions.

In July 2020, Magtism, the global leader in Transcranial Magnetic Stimulation (TMS), announced an agreement to acquire the product portfolio of Electrical Geodesics Inc. from Royal Philips. Magtism acquired EGI hardware, sensor net assets, and software and handle global sales.

Nihon Kohden America Inc. has introduced its EMG/NCV/EP measuring desktop system with a six or twelve-channel amplifier and up to two electrical stimulators.

Key Players:

Compumedics Limited

Cadwell Laboratories Inc.

Covidien Limited

Electrical Geodesics Inc.

Natus Medical Inc.

Nihon Kohden America Inc.

NeuroWave Systems Inc.

Noraxon U.S.A. Inc.

Key Segments Covered:

By Modality:

Portable

Standalone

By End User:

Clinics

Hospitals

Rehabilitation Centers

Homecare Centers

By Region:

North America

United States

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Europe

Germany

United Kingdom

France

Spain

Russia

Rest of Europe

Japan

Asia Pacific Excluding Japan

China

India

Malaysia

Singapore

Australia

Rest of Asia Pacific Excluding Japan (APEJ)

The Middle East and Africa

GCC Countries

Israel

South Africa

Middle East and Africa (MEA)

[insightslicelive]

Electromyography Devices Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | NIHON KOHDEN, Cadwell Industries, Compumedics

Electromyography Devices Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | NIHON KOHDEN, Cadwell Industries, Compumedics

insightSLICE publishes a Global Electromyography Devices Market from 2023 to 2032 research report that assesses the industry and significant market trends, as well as historical and forecasted market data. The study also includes market overview, as well as definitions and applications. Get a FREE Sample Copy @ https://www.insightslice.com/request-sample/1159 The exhaustive Electromyography…

[blogponly]

Neurodiagnostics Market: Navigating Regulatory Changes and Embracing Innovation

In the latest report from Emergen Research, the market research report discusses the global Neurodiagnostics market in depth, and each of the major market segments is examined in depth. In addition to market information, the report provides industry statistics, regional market revenue shares, gross profits, production & distribution costs, and product portfolios related to the global Neurodiagnostics market. There are also a number of factors influencing industry revenue growth identified in the report, including drivers, opportunities, trends, restraints, challenges, demand and supply ratios, production and consumption patterns, stringent regulatory frameworks, as well as a multitude of other micro- and macro-economic factors.

The global neurodiagnostics market size is expected to reach USD 14.83 Billion and register a steady revenue CAGR of 7.3% in 2032, according to latest analysis by Emergen Research. Neurodiagnostics market revenue growth is expected to be driven by increasing patient awareness and focus on early disease detection. For instance, on 09 February 2023, it was announced that QuantalX Neuroscience Ltd. and NeuroSense Therapeutics Ltd. will work together to advance the early detection and treatment of neurodegenerative illnesses. QuantalX Neuroscience Ltd. is an organization that develops drugs for the clinical stage. With the help of real-time brain functioning monitoring, QuantalX's Delphi-MD is a ground-breaking medical device that bridges the neurodiagnostic gaps that clinicians face at the point of treatment, improving patient care and lowering related costs.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/1786

Global Neurodiagnostics Market Highlights:

Regional demand estimation and forecast

Product Mix Matrix

R&D Analysis

Cost-Benefit Analysis

Pre-commodity pricing volatility

Supply chain optimization analysis

Technological updates analysis

Raw Material Sourcing Strategy

Competitive Analysis

Mergers & Acquisitions

Location Quotients Analysis

Carbon Footprint Analysis

Patent Analysis

Vendor Management

Market Overview:

The report bifurcates the Neurodiagnostics market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Based on the types, the market is segmented into:

Product Outlook (Revenue, USD Billion; 2019–2032)

Diagnostic and Imaging Systems

Electroencephalogram (EEG) Systems

Electromyography (EMG) Products

Magnetic Resonance Imaging (MRI) Systems

Ultrasound Imaging Systems

Computed Tomography (CT) Scanner

Magnetoencephalogram (MEG) System

Position emission tomography (PET) System

Angiography System

Others

Clinical Testing Instruments

PCR

Next-Generation Sequencing (NGS)

Sanger Sequencing

Others

Reagents & Consumables

Media and Serra

Solvents

Enzymes, Protein & Peptides

Probes

Buffers

Antibodies

Others

Condition Outlook (Revenue, USD Billion; 2019–2032)

Neuro Degenerative Diseases

Epilepsy

Stroke

Headache Disorders

Sleep Disorders

Others

End-Use Outlook (Revenue, USD Billion; 2019–2032)

Hospitals and Surgery Centers

Neurology Centers

Ambulatory Care Centers

Diagnostic Laboratories & Imaging Centers

Research Laboratories & Academic Institutes

Request a discount on the report @ https://www.emergenresearch.com/request-discount/1786

Competitive Landscape:

The latest study provides an insightful analysis of the broad competitive landscape of the global Neurodiagnostics market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Neurodiagnostics market and pinpoint the fundamental growth trends.

Regional Landscape section of the Neurodiagnostics report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/neurodiagnostics-market

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Neurodiagnostics market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

Key Companies Profiled in the Report are:

GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Hitachi, Ltd., Canon Inc., Lifelines Neuro, Natus Medical Incorporated, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, Mitsar Co. LTD

Additional information offered by the report:

Along with a complete overview of the global Neurodiagnostics market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.

The report elaborates on the global Neurodiagnostics market size and share governed by the major geographies.

It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.

Thank you for reading our report. To know more about the customization feature, please get in touch with us, and our team will ensure the report is customized to meet your requirements.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

[mrudula01]

Epilepsy Devices Market: Tech Trends 2022-2028

Lifesciences

09, December 2022

According to the WHO, epilepsy is a chronic brain disorder that affects 50 million individuals, making it one of the most prevalent neurological conditions worldwide. It is estimated that with access to early detection and appropriate care, 70% of the population diagnosed with epilepsy may live seizure-free. According to our estimates, the global epilepsy devices market was valued at $669.73 million in 2021 and is expected to reach $1157.58 million by 2028, growing at a CAGR of 8.16% during the forecast period 2022-2028.

Government institutions worldwide are focused on starting initiatives to create innovative epilepsy devices with AI and machine learning integration. Additionally, organizations that support research need to encourage high-quality comparative efficacy trials and sufficient data to guide therapeutic practice in epilepsy. As a result of these technologically advanced equipment and increasing drug trials, the market for epilepsy devices is anticipated to grow throughout the forecast period.

Epilepsy Devices - Key Detection Methodologies

Currently, several wearable technologies can detect seizures, collect data, and alert caregivers. Although with technological advancements, the ability to detect seizure-related alterations increases. Top trends backing this tech boom include:

Wearable devices are estimated to be the fastest-growing device type during the forecast period. Monitoring epileptic patients is crucial, as 20% of epileptics only have seizures while asleep, 40% only have seizures while awake, and 35% have seizures both when they are awake and asleep. With technologically advanced non-invasive wearable sensors, measuring accelerometry, photoplethysmography (PPG), electrodermal activity (EDA), electromyography (EMG), and other signals outside of the conventional clinical environment have become effective.

Vagus Nerve Stimulation (VNS) has emerged as the fastest-growing application category. VNS Therapy has been approved by the U.S. Food and Drug Administration (FDA) as an add-on therapy for age 4 years and above to treat drug-resistant epilepsy or refractory epilepsy. VNS has been reportedly beneficial in many patients, including the ones with posttraumatic epilepsy (PTE). PTE is a common consequence of traumatic brain injury and accounts for about 20% of symptomatic epilepsy cases.

As per estimates, Electroencephalography lead the detection and prediction devices type segment in 2021 and is expected to maintain its stronghold during the forecast period. There is growing interest in wearable or mobile EEG solutions that allow long‐term EEG monitoring in an easy‐to‐use format. Despite the availability of these new EEG solutions, their adoption is still limited in clinical practice, mainly because of the unfamiliarity of healthcare and biomedical research sectors with the technology and its application.

Strategic Initiatives and Government Approvals

Different end-users, such as homecare settings, hospitals, and clinics, are utilizing epilepsy devices. The manufacturers of epilepsy monitoring devices are likely to gain prominent business opportunities from the hospital & clinics segment owing to the rise in the use of EEG monitoring and emergency medical services.

The government authorities of several developing nations, including India and China, are focusing on developing sturdy healthcare infrastructure. As a result, operating players are expected to gain sizable growth prospects in the region during the forecast period. Owing to this, the Asia Pacific epilepsy devices market is anticipated to witness the fastest growth with a CAGR of 8.38% throughout the forecast period.

In addition, companies are also focusing on launching novel devices for children. Moreover, companies are also using organic and inorganic strategies, including mergers and acquisitions, to stay ahead of the competition. Some of these include:

In September 2022, Boston Scientific Corporation’s current-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling. The company also received FDA 510(k) clearance for the EMBOLD Fibered Detachable Coil, which reduces the blood flow rate in the peripheral vasculature.

In July 2022, Medtronic PLC received FDA 510(k) clearance for its UNiD Spine Analyzer v4.0 planning platform to leverage machine learning.

In November 2021, NeuroPace, Inc. received an Investigational Device Exemption (IDE) from the FDA to study the company’s RNS System to treat primary generalized epilepsy in patients aged 12 and above.

Way Forward

With technological advancements, epilepsy detection devices with exceptionally low false alarm rates have recently been developed. They are based on computationally intensive algorithms and employed in implanted systems for pre-surgical monitoring. Recent research has produced encouraging findings for probabilistic seizure risk projections using long-term wearable technology and electronic seizure diaries. The symptoms, mood, and cognitive function of an individual may also have predictive significance. Therefore, technological advances in non-invasive wearable sensors are anticipated to create growth opportunities for the epilepsy devices market.

FAQ:

Q1) What are the key end-users of the epilepsy devices market?

The key end-users in the epilepsy devices market include hospitals & clinics, neurology centers, homecare settings, and other end-users.

Q2) Which region leads the global epilepsy devices market?

North America leads the global epilepsy devices market.